WASHINGTON, D.C. – The Health subcommittee for the U.S. House Committee on Energy and Commerce on Wednesday held a three-plus hours-long hearing on the topic of “Cannabis Policies for the New Decade,” which examined legislative proposals that would allow significant federal policy reform, if passed. Wednesday’s hearing focused mainly on cannabis research. In his opening […]
Food and Drug Administration
Business, California, CBD products, CBD regulations, Charlotte's Web, class action lawsuit, FD&C Act, FDA, fda warning letters, FDCA, Federal Courts, Federal Food Drug and Cosmetic Act, Florida, Food and Drug Administration, Green Roads, Infinite CBD, lawsuit, Legal & Politics, Ursula Ungaro
Anxious CBD producers may be able to breathe a sigh of relief, at least for now. In a move that could set precedent, a federal judge in Florida recently placed a hold on a lawsuit filed against Florida-based CBD manufacturer Green Roads. U.S. District Judge Ursula Ungaro ruled CBD manufacturers should not be subjected to […]
Anna G. Eshoo, Barbara Lee, Bloomberg Law, cannabis news, cannabis reform bills, Controlled Substances Act, CSA, DEA, Department of Veterans Affairs, Drug Enforcement Administration, Earl Blumenauer, FDA, Featured Story, federal marijuana laws, Food and Drug Administration, H.R. 1151, H.R. 171, H.R. 2843, H.R. 3797, H.R. 3884, H.R. 601, Hakeem S. Jeffries, House Energy and Commerce Health Subcommittee, Jerrold Nadler, Legitimate Use of Medicinal Marihuana Act, Marijuana Freedom and Opportunity Act, Marijuana Opportunity Reinvestment and Expungement Act of 2019, marijuana research, Matt Gaetz, Medical Cannabis Research Act of 2019, Medical Marijuana Research Act of 2019, Morgan Griffith, National Institute on Drug Abuse, National Institutes of Health, NIH, VA, Veterans Medical Marijuana Safe Harbor Act
WASHINGTON, D.C. – 2020 could be shaping up to be a major turning point for federal cannabis law. Multiple cannabis reform bills will be debated by the congressional committee of House Energy and Commerce’s subcommittee on Health this Wednesday. According to a memo about the meeting, a total of six bills will be included in […]
Alex Azar, black market, donald trump, e-cigarettes, FDA, Food and Drug Administration, Health and Human Services, HHS, JAMA, Journal of the American Medical Association, Legal & Politics, National Youth Tobacco Survey, NYTS, Operation Vapor Lock, restrictions, tobacco vape products, trump administration, underage use, vape products
WASHINGTON, D.C. – The U.S. Food and Drug Administration (FDA) today released new policy and restrictions on flavored e-cigarettes that amounts to a ban of such products, with the exception of tobacco and menthol flavors. “Companies that do not cease manufacture, distribution, and sale of unauthorized flavored cartridge-based e-cigarettes (other than tobacco or menthol) within […]
SILVER SPRING, Md. – The U.S. Food and Drug Administration and the Drug Enforcement Administration seized forty-four websites offering to sell illicit vaping cartridges containing tetrahydrocannabinol (THC), the primary psychoactive component of the cannabis plant. The action, which is part of Operation Vapor Lock, reflects ongoing work by federal, state and local authorities to investigate […]
2018 Farm Act, Advertising, CBD, Charlotte's Web, class action lawsuit, Colorado, district court, FDA, Featured Story, federal policy, Federal Trade Commission, Food and Drug Administration, FTC, health claims, Hemp, Infinite CBD, labeling, Legal, Legal & Politics, Mitch McConnell, Northern California, nutritional, Prohibition, regulatory, supplements, U.S. Department of Agriculture, USDA
BOULDER, Colo. – Two Colorado-based CBD product manufacturers, Charlotte’s Web Holdings, Inc. and Infinite Product Company, LLC, better known as Infinite CBD, are apparently to be named as defendants in class action lawsuits—both reportedly filed in California. Charlotte’s Web, a pioneer in the CBD product industry, issued a press release Monday stating it had become […]
The former head of the U.S. Food and Drug Administration (FDA) has aimed a shot across the bows of the CBD industry by declaring it ‘not safe’.
While the FDA has yet to pronounce on the status of CBD, at a federal level, the industry will resolutely hope that Scott Gottlieb’s latest pronouncement is not indicative of his former employer’s position.
The former FDA commissioner, who stepped down from his post earlier this year, made his opinions clear in a series of tweets, reports The Motley Fool website. Stating that ‘CBD hype has outpaced science’ and that CBD is not safe’, he says the FDA needs to move quickly to oversee the ‘production, quality, and purity levels of CBD products’.
And he goes on to say ‘all non-compliant producers, or those who fail to meet rigorous purity and quality standards, should be removed from the marketplace’, the report continued.
Following hearings in to the CBD phenomenon, in May this year, the FDA indicated it would be in a position to outline it guidelines for the CBD industry ‘by early fall’ – and with Christmas on the horizon the industry is still waiting.
The passing of last year’s Farm Bill boosted hemp production, supporting the boom in the U.S CBD industry. The Brightfield Group estimates U.S. CBD sales will grow from around $600 million in 2018 to $23.7 billion by 2023.
But CBD, as a cannabinoid found in the cannabis plant, is still illegal at a federal level, and the industry is looking for regulatory clarity from the FDA. Meanwhile the U.S. The National Consumers League (NCL) has announced a new initiative; Consumers for Safe CBD.
Consumers for Safe CBD say CBD is ‘a clear and present public health issue’ and is pressing for speedy FDA regulation.
Sally Greenberg, Executive Director of NCL, said: “Consumers are being told these products will cure their chronic illnesses and help their anxious pets or children. Yet there is no scientific evidence behind the claims. What’s even more concerning is that without FDA’s stamp of approval, we do not know what is in these products…(which) may contain contaminants and ingredients that could harm consumers.”
She said Consumers for Safe CBD is calling for ‘gold standard testing of CBD by the FDA’.
A rapidly-growing database of clinical evidence, from trials and first-hand patient experience, demonstrate that CBD can help with a number of conditions including; inflammation, arthritis, pain management and anxiety.
For more stories like this one, subscribe to the CBD Business Weekly Newsletter.
The U.S. Food and Drug Administration on Friday issued an updated consumer alert warning people not use vaping products containing THC, though it makes no mention of recommendations for cannabis businesses. The statement from FDA Commissioner Norman Sharpless notes that “the FDA does not have enough data to identify the cause, or causes, of the […]
Aaron Smith, Alcohol and Tobacco Tax and Trade Bureau, Congress, Controlled Substances Act, Cova Software, DEA, Drug Enforcement Administration, FDA, Featured Story, federal government, Food and Drug Administration, greenlane, Ionic, Ionic Brands, Legal & Politics, legalization, ncia, sc labs, TTB, U.S. House of Representatives, Vaping, Vaping Crisis, Vaping Death, vaping illness
WASHINGTON, D.C. – The National Cannabis Industry Association (NCIA) today delivered a letter to the U.S. House of Representatives urging Congress to take federal action in order to mitigate the nation’s ongoing epidemic of vaping-related illness. The letter, signed by approximately 800 individuals, included signatories from dozens of cannabis businesses such as SC Labs, Greenlane, […]
Anne Schuchat, black market, bootleg vapes, California, cannabis, cannabis news, CDC, CDC report, Centers for Disease Control, Dank Vapes, DEA, deaths, Drug Enforcement Adminsitration, e-cigarettes, e-liquid, fatalities, FDA, Featured Story, flavored vape products, Food and Drug Administration, Illinois, investigation, Jay Inslee, Jennifer Layden, local officials, Los Angeles, lung injury, Massachusetts, Michigan, Morbidity and Mortality Weekly Report, New York, nicotine, Oregon, public health state officials, pulmonary, respiratory, rhode island, tobacco, toxic, underage vaping, vape dealers, Vapes, Vaping, Vaping Ban, vaping device, vaping illness, Washington State, wisconsin
WASHINGTON, D.C. – The Centers for Disease Control (CDC) on Friday gave a telephone press conference to update the latest information on the vaping-related respiratory condition that has spread across the U.S. since late August, resulting in fatalities and hundreds of affected patients. “As of September 24, 805 confirmed and probable cases of lung injury […]